A Breakthrough Point in Integrative Medical Research:Challenge of Treating Overlapping Symptoms in Functional Gastrointestinal Disorders

Xu-dong TANG; Xiang-xue MA

doi:10.1007/s11655-022-3534-7

Your Location：

Home >

Browse articles >

A Breakthrough Point in Integrative Medical Research:Challenge of Treating Overlapping Symptoms in Functional Gastrointestinal Disorders

Thinking and Methodology | Updated：2022-06-27

- A Breakthrough Point in Integrative Medical Research:Challenge of Treating Overlapping Symptoms in Functional Gastrointestinal Disorders
- Chinese Journal of Integrative Medicine Vol. 28, Issue 6, Pages: 554-559(2022)
- Affiliations：
  
  Institute of Spleen and Stomach Diseases, Xiyuan Hospital,China Academy of Chinese Medical Sciences, Beijing (100091),China
- Author bio：
  
  Prof. TANG Xu-dong, E-mail: txdly@sina.com
- Funds：
- DOI：10.1007/s11655-022-3534-7
  CLC：
- Published：01 June 2022，
  
  Accepted：03 March 2022
Scan for full text
Xu-dong TANG, Xiang-xue MA. A Breakthrough Point in Integrative Medical Research:Challenge of Treating Overlapping Symptoms in Functional Gastrointestinal Disorders. [J]. Chinese Journal of Integrative Medicine 28(6):554-559(2022)
DOI：

Xu-dong TANG, Xiang-xue MA. A Breakthrough Point in Integrative Medical Research:Challenge of Treating Overlapping Symptoms in Functional Gastrointestinal Disorders. [J]. Chinese Journal of Integrative Medicine 28(6):554-559(2022) DOI： 10.1007/s11655-022-3534-7.

摘要

功能性胃肠病症状(FGIDs)重叠临床常见

症状持续或反复发作

影响患者的生活质量并造成重大社会经济负担

是目前临床诊疗的难题. 中医药疗法以其整体调节和个体化治疗特点有望成为破解FGIDs症状重叠难题的有力手段. 本文将就功能性胃肠病症状重叠诊疗现状、中医药的优势和特色以及结合医学如何作出突破进行论述.

Abstract

Functional gastrointestinal disorders (FGIDs) are common disorders that are characterized by persistent and recurring gastrointestinal symptoms. Many patients with FGIDs have overlapping symptoms

which impaired the quality of life and ability to work of patients

and left a considerable impact on health-care systems and society. Chinese medicines (CMs) are commonly utilized by many patients with FGIDs. This article discusses the current status of diagnosis and treatment of FGIDs

the advantages and characteristics of CM treatment

and how integrated medicine can make a breakthrough in FGIDs diagnosis and treatment.

关键词

Keywords

functional gastrointestinal disordersoverlapping symptomsintegrative medicine

references

Ke MY. Functional gastrointestinal disorders are not just simple disorders of functions. Chin J Pract Intern Med (Chin)2006;26:721-722.

Cremonini F, Talley NJ. The overlap between functional dyspepsia and irritable bowel syndrome–a tale of one or two disorders? Aliment Pharmacol Therapeutic 2004;20:40-49.

Masuy I, van Oudenhove L, Tack J. Review article:treatment options for functional dyspepsia. Aliment Pharmacol Therapeutics 2019;49:1134-1172.

Tan N, Gwee KA, Tack J, Zhang M, LI Y, Chen M,et al. Herbal medicine in the treatment of functional gastrointestinal disorders: a systematic review with meta-analysis. J Gastroenterol Hepatol 2020;35:544-556.

Xiong L, Gong X, Siah KTH, Pratap N, Ghoshal UC,Abdullah M, et al. Rome foundation Asian working team report: real world treatment experience of Asian patients with functional bowel disorders. J Gastroenterol Hepatol 2017;32:1450-1456.

Lv L, Wang FY, Ma XX, Li ZH, Huang SP, Shi ZH, et al. Efficacy and safety of Xiangsha Liujunzi Granules for functional dyspepsia: a multi-center randomized double-blind placebo-controlled clinical study. World J Gastroenterol 2017;30:5589-5601.

Aziz I, Palsson OS, Törnblom H, Sperber AD, Whitehead WE, Simrén M. Epidemiology, clinical characteristics,and associations for symptom-based Rome Ⅳ functional dyspepsia in adults in the USA, Canada, and the UK:a cross-sectional population-based study. Lancet Gastroenterol Hepatol 2018;3:252-262.

Rasmussen S, Jensen TH, Henriksen SL, Haastrup PF,Larsen PV, Jens Sondergaard, et al. Overlap of symptoms of gastroesophageal reflux disease, dyspepsia and irritable bowel syndrome in the general population. Scandinavian J Gastroenterol 2015; 50:162-169.

Wang A, Liao XH, Xiong LS, Sui P, Chen MH. The clinical overlap between functional dyspepsia and irritable bowel syndrome based on Rome Ⅲ criteria. BMC Gastroenterol 2008;8:1-7.

Von Wulffen M, Talley NJ, Hammer J, McMaster J,Holtmann G. Overlap of irritable bowel syndrome and functional dyspepsia in the clinical setting: prevalence and risk factors. Digest Dis Sci 2019;64:480-486.

De Bortoli N, Martinucci I, Bellini M. Overlap of functional heartburn and gastroesophageal reflux disease with irritable bowel syndrome. World J Gastroenterol 2013;19:5787.

Ghoshal UC, Singh R. Frequency, and risk factors of functional gastro-intestinal disorders in a rural Indian population. J Gastroenterol Hepatol 2017;32:378-387.

Yao X, Yang YS, Cui LH, Gang S, Xiao LZ. The overlap of upper functional gastrointestinal disorders with irritable bowel syndrome in Chinese outpatients: a multicenter study. J Gastroenterol Hepatol 2016;31:1584-1593.

Lu CL, Lang HC, Chang FY, Chen CY, Luo JC, Wang SS,et al. Prevalence and health/social impacts of functional dyspepsia in Taiwan: a study based on the Rome criteria questionnaire survey assisted by endoscopic exclusion among a physical check-up population. Scand J Gastroenterol 2005;4:402-411.

Pleyer C, Bittner H, Locke Ⅲ GR, Choung RS, Zinsmeister AR, Schleck CD, et al. Overdiagnosis of gastro-esophageal reflux disease and underdiagnosis of functional dyspepsia in a USA community. Neurogastroenterol Motil 2014;26:1163-1171.

Song ZQ, Ke MY, Wang ZF, Liu XH, Fang XC. Dyspeptic symptomatology and pathogenesis of functional dyspepsia with and without overlapping symptoms: a comparative study. Chin J Gastroenterol 2006;11:458-461.

Koloski NA, Jones M, Talley NJ. Evidence that independent gut-to-brain and brain-to-gut pathways operate in the irritable bowel syndrome and functional dyspepsia: a 1-year population-based prospective study. Aliment Pharmacol Therapeutic 2016;44:592-600.

Pinto-Sanchez MI, Ford AC, Avila CA, Verdu EF, Collins SM, Morgan D. Anxiety and depression increase in a stepwise manner in parallel with multiple FGIDs and symptom severity and frequency. Am J Gastroenterol 2015;110:1038-1048.

Piacentino D, Cantarini R, Alfonsi M, Crudeli A, Vernia P,Biondi M. Psychopathological features of irritable bowel syndrome patients with and without functional dyspepsia: a cross sectional study. BMC Gastroenterol 2011;11:1-6.

Savas LS, White DL, Wieman M, Daci K, Fitzgerald S, Laday Smith S, et al. irritable bowel syndrome and dyspepsia among women veterans: prevalence and association with psychological distress. Aliment Pharmacol Therapeutic 2009;29:115-125.

Ke MY, Song ZQ. New considerations on overlapping symptoms of functional gastrointestinal disorders. Chin J Gastroenterol 2006;11:449-450.

De Bortoli N, Tolone S, Frazzoni M, Martinucci I, Sgherri G, Albano E, et al. Gastroesophageal reflux disease,functional dyspepsia and irritable bowel syndrome: common overlapping gastrointestinal disorders. Annals Gastroenterol 2018;31:639.

Chandran S, Prakrithi SN, Mathur S, Rao T. A review of functional gastrointestinal disorders: a primer for mental health professionals. Arch Mental Health 2018;19:70.

Morris-Yates A, Talley NJ, Boyce PM, Nandurkar BSJ,Gavin A. Evidence of a genetic contribution to functional bowel disorder. Am J Gastroenterol 1998;93:1311-1317.

Sperber AD, Bangdiwala SI, Drossman DA, Ghoshal UC,Simren M, Tack J, et al. Worldwide prevalence and burden of functional gastrointestinal disorders, results of Rome Foundation global study. Gastroenterology 2021;160:99-114. e3.

Peery AF, Dellon ES, Lund J, Crockett SD, McGowan CE,Bulsiewicz WJ, et al. Burden of gastrointestinal disease in the United States: 2012 update. Gastroenterology 2012;143:1179-1187. e3.

Zou DW. Development of gastrointestinal motility and functional gastrointestinal disorders in the past 40 years.Chin J Digest (Chin) 2021;41:145-148.

Liu Q, Shi Z, Zhang T, Jiang T, Luo X, Su X, et al. Efficacy and safety of Chinese herbal medicine Xiao Yao San in functional gastrointestinal disorders: a meta-analysis and trial sequential analysis of randomized controlled trials.Front Pharmacol 2022;12:821802.

Yang DY. Clinical observation on Simo Decoction for treating functional gastrointestinal disorders with Gan and Pi qi stagnation syndrome. Guangming J Chin Med (Chin)2018;33:2535-2537.

Xu SP, Zha H, Hou XH, Gao Z, Zhang Y, Chen JDZ.Electroacupuncture accelerates solid gastric emptying in patients with functional dyspepsia. Gastroenterol 2004;126:A437.

Tang X, Zhang S, Hou X, Li ZH, Chen SN, Feng PM, et al.Postmarketing re-evaluation of Tongxiening Granules in treatment of diarrhea-predominant irritable bowel syndrome:a multi-center, randomized, double-blind, double-dummy and positive control trial. Chin J Integr Med 2019;25:887-894.

Liu BY, Wu J, Yan SY, Zhou KH, He LY, Fang JQ, et al.Electroacupuncture vs prucalopride for severe chronic constipation: a multicenter, randomized, controlled,noninferiority trial. Am J Gastroenterol 2021;116:1024-1035.

Cremonini F. Standardized herbal treatments on functional bowel disorders: moving from putative mechanisms of action to controlled clinical trials. Neurogastroenterol Motil 2014;26:893-900.

Xiao HT, Zhong L, Tsang SW, Lin ZS, Bian ZX. Traditional Chinese medicine formulas for irritable bowel syndrome:from ancient wisdoms to scientific understandings. Am J Chin Med 2015;43:1-23.

Xiao YL, Li YW, Shu JC, Li Y, Xu JM, Liu DL, et al. The efficacy of oral Zhizhu Kuanzhong, a traditional Chinese medicine, in patients with postprandial distress syndrome. J Gastroenterol Hepatol 2019;34:526-531.

Cai FF, Zhou WJ, Wu R, Su SB. Systems biology approaches in the study of Chinese herbal formulae. Chin Med 2018;13:65.

Lo HY, Li CC, Huang HC, Lin LJ, Hsiang CY, Ho TY.Application of transcriptomics in Chinese herbal medicine studies. J Tradit Complement Med 2012;2:105-114.

More>

Views

Downloads

CSCD

Alert me when the article has been cited

Submit

Tools

Publicity Resources

Reframing Palliative Care: An East-West Integrative Palliative Care Model

Monoclonal Gammopathy of Renal Significance (MGRS):Prospects for Treatment in Integrated Chinese and Western Medicine

Analysis on Situation of Traditional Chinese Medicine Development and Protection Strategies in China

Current Situation and Reconsideration on Study of Integrated Chinese and Western Medicine Andrology

Integrative Medicine on Optimizing Clopidogrel and Aspirin Therapy

Related Author

No data

Related Institution

Department of Medicine, David Geffen School of Medicine,University of California Los Angeles

Center for East-West Medicine, Department of Medicine, David Geffen School of Medicine, University of California Los Angeles

Department of Nephrology, Guang'anmen Hospital, China Academy of Chinese Medical Sciences

Intellectual Property Research Center, School of Law, Xi'an Jiaotong University

Andrology Department of Integrative Medicine, Zhongda Hospital, School of Medicine, Southeast University

Address：1 Caochang, xiyuan, Beijing, People's Republic of China Postal code：100091
Tel：010-62886827, 62877592 Fax：010-62874291
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备05067934号-1 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰